Clinical Trials Arena on MSN
Lundbeck’s migraine prevention drug meets primary endpoint in Phase IIb trial
Lundbeck will advance the IV formulation of the drug to Phase III trials after the successful Phase IIb trial.
Q1 2026 Management View CEO Mitchell Steiner stated that Veru is advancing its late-stage clinical pipeline, focusing on two oral small molecule drugs: enobosarm, a selective androgen receptor ...
Poster published at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting shows the final 5 year safety data from the Phase IIb breast cancer clinical trial. Final safety conclusions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results